USPatent applicationPatented

Substituted cycloalkenopyrazoles as BUB1 inhibitors for the treatment of cancer

Granted 16 Aug 2016 · 1 office action

Life of the application

10 dated events
⤢ drag to zoom20142016201820202022202420262028203020322034ProsecutionTerm & fees
ProsecutionTerm & feeshover for detail · click to open

Abstract

Compounds of formula (I), processes for their production and their use as Bub1 kinase inhibitors for the treatment of hyperproliferative diseases and/or disorders responsive to induction of cell death. [structure]

Claims as granted

13 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

8 codes
IPC · International Patent Classification
Section A — Human necessities
  • A61K31/506
  • A61K45/06
  • A61K31/695
  • A61K31/5377
Section C — Chemistry; metallurgy
  • C07D403/04
  • C07F7/18
  • C07D401/14
  • C07D405/14

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJul 2013Jan 2014Jul 2014Jan 2015Jul 2015Jan 2016Jul 2016USPTOApplicantNon-final rejectionResponse after non-finalRequest for continued examinationRequest for continued examination
USPTOApplicanthover for detail · click to open
Pendency
3.3 y
1,196 days filing → grant
Office actions
1
non-final + final
Responses
2
2 RCE
Examiner
Alexander R Pagano
art unit 1624 · TC 1600
Citations: 66 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

No assignments have been recorded for this application yet.